Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 31% ± 9% | |
GABAergic neuron | 3 studies | 27% ± 4% | |
glutamatergic neuron | 3 studies | 28% ± 2% |
Insufficient scRNA-seq data for expression of SLC22A4 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 193.62 | 2607 / 2642 | 100% | 7.64 | 702 / 705 |
prostate | 100% | 244.78 | 244 / 245 | 96% | 6.46 | 484 / 502 |
kidney | 100% | 331.30 | 89 / 89 | 93% | 11.00 | 838 / 901 |
breast | 93% | 172.36 | 429 / 459 | 95% | 5.76 | 1064 / 1118 |
adrenal gland | 100% | 182.42 | 258 / 258 | 88% | 6.70 | 203 / 230 |
lung | 99% | 318.78 | 571 / 578 | 87% | 2.91 | 1001 / 1155 |
ovary | 99% | 225.65 | 179 / 180 | 86% | 2.58 | 368 / 430 |
intestine | 97% | 202.51 | 938 / 966 | 85% | 2.41 | 449 / 527 |
bladder | 100% | 102.48 | 21 / 21 | 77% | 2.18 | 386 / 504 |
uterus | 99% | 147.41 | 168 / 170 | 77% | 2.44 | 353 / 459 |
thymus | 90% | 88.53 | 589 / 653 | 85% | 2.48 | 512 / 605 |
skin | 87% | 191.74 | 1568 / 1809 | 66% | 2.78 | 312 / 472 |
esophagus | 54% | 51.12 | 785 / 1445 | 86% | 2.34 | 157 / 183 |
stomach | 43% | 39.77 | 153 / 359 | 83% | 2.39 | 238 / 286 |
pancreas | 18% | 12.02 | 60 / 328 | 94% | 3.39 | 168 / 178 |
spleen | 100% | 523.17 | 241 / 241 | 0% | 0 | 0 / 0 |
muscle | 100% | 403.52 | 799 / 803 | 0% | 0 | 0 / 0 |
adipose | 96% | 164.79 | 1160 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 89% | 114.60 | 1187 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 2623.98 | 759 / 929 | 0% | 0 | 0 / 0 |
heart | 82% | 117.53 | 702 / 861 | 0% | 0 | 0 / 0 |
liver | 31% | 34.29 | 69 / 226 | 41% | 1.95 | 168 / 406 |
tonsil | 0% | 0 | 0 / 0 | 71% | 1.98 | 32 / 45 |
eye | 0% | 0 | 0 / 0 | 31% | 0.57 | 25 / 80 |
lymph node | 0% | 0 | 0 / 0 | 17% | 0.44 | 5 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015697 | Biological process | quaternary ammonium group transport |
GO_0042908 | Biological process | xenobiotic transport |
GO_0089718 | Biological process | amino acid import across plasma membrane |
GO_1902603 | Biological process | carnitine transmembrane transport |
GO_0009437 | Biological process | carnitine metabolic process |
GO_0006814 | Biological process | sodium ion transport |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_1901374 | Biological process | acetate ester transport |
GO_0006836 | Biological process | neurotransmitter transport |
GO_0015879 | Biological process | carnitine transport |
GO_0016324 | Cellular component | apical plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0009925 | Cellular component | basal plasma membrane |
GO_0015171 | Molecular function | amino acid transmembrane transporter activity |
GO_0015651 | Molecular function | quaternary ammonium group transmembrane transporter activity |
GO_0015293 | Molecular function | symporter activity |
GO_0015226 | Molecular function | carnitine transmembrane transporter activity |
GO_0008513 | Molecular function | secondary active organic cation transmembrane transporter activity |
GO_0030165 | Molecular function | PDZ domain binding |
GO_0015199 | Molecular function | amino-acid betaine transmembrane transporter activity |
GO_0005277 | Molecular function | acetylcholine transmembrane transporter activity |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC22A4 |
Protein name | Solute carrier family 22 member 4 (Ergothioneine transporter) (ET transporter) (ETTh) (Organic cation/carnitine transporter 1) (OCTN1) Solute carrier family 22 member 4 |
Synonyms | ETT OCTN1 UT2H |
Description | FUNCTION: Transporter that mediates the transport of endogenous and microbial zwitterions and organic cations . Functions as a Na(+)-dependent and pH-dependent high affinity microbial symporter of potent food-derived antioxidant ergothioeine . Transports one sodium ion with one ergothioeine molecule (By similarity). Involved in the absorption of ergothioneine from the luminal/apical side of the small intestine and renal tubular cells, and into non-parenchymal liver cells, thereby contributing to maintain steady-state ergothioneine level in the body . Also mediates the bidirectional transport of acetycholine, although the exact transport mechanism has not been fully identified yet . Most likely exports anti-inflammatory acetylcholine in non-neuronal tissues, thereby contributing to the non-neuronal cholinergic system . Displays a general physiological role linked to better survival by controlling inflammation and oxidative stress, which may be related to ergothioneine and acetycholine transports . May also function as a low-affinity Na(+)-dependent transporter of L-carnitine through the mitochondrial membrane, thereby maintaining intracellular carnitine homeostasis . May contribute to regulate the transport of cationic compounds in testis across the blood-testis-barrier . . |
Accessions | D9N2T6 ENST00000200652.4 Q9H015 |